Compare Sentral Mitra Informatika Tbk. (LUCK) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sentral Mitra Informatika Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Sentral Mitra Informatika Tbk. trades at Rp117 (market cap 85.17B, 982.9K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Organon Pharma Indonesia Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| LUCK | SCPI | |
|---|---|---|
Market Cap | 85.17B | 104.4B |
Volume | 982.9K | — |
Lot | 9.83K | — |
Turnover | 114.55M | — |
Average Price | 116.55 | — |
Value | 114.55M | — |
Indicative Equilibrium Price | 116 | — |
Indicative Equilibrium Volume | 183 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sentral Mitra Informatika Tbk.
PT Sentral Mitra Informatika Tbk (the Company), was established in the Republic of Indonesia under the framework of the Domestic Capital Investment Law No. 6 year 1968 based on notarial Deed No. 11 dated November 14, 2008 of Henny Hendrawati Putradjaja, S.H., Notary in Jakarta.
Read more on LUCK →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
